Listed

Adicet Bio, Inc.

ACETNasdaqCIK 1720580HealthcareFiscal year ends Dec 26

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$22.3m, Q2 FY2026
Net income−$21.4m, Q2 FY2026
Adicet Bio, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m26.2Research and development, Q3 FY2023, three months to 2023-09-30$26.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure24.8Research and development, Q4 FY2023, three months to 2023-12-31$24.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0000950170-25-034587. Derived: 12-month figure less the 9-month figure.Report this figure23.9Research and development, Q1 FY2024, three months to 2024-03-31$23.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure25.9Research and development, Q2 FY2024, three months to 2024-06-30$25.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure26.3Research and development, Q3 FY2024, three months to 2024-09-30$26.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure23.3Research and development, Q4 FY2024, three months to 2024-12-31$23.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure22.8Research and development, Q1 FY2025, three months to 2025-03-31$22.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure28.4Research and development, Q2 FY2025, three months to 2025-06-30$28.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure22.9Research and development, Q3 FY2025, three months to 2025-09-30$22.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure25.0Research and development, Q4 FY2025, three months to 2025-12-31$25.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure17.5Research and development, Q1 FY2026, three months to 2026-03-31$17.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure18.5Research and development, Q2 FY2026, three months to 2026-06-30$18.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Operating income$m(52.3)Operating income, Q3 FY2023, three months to 2023-09-30−$52.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure(31.6)Operating income, Q4 FY2023, three months to 2023-12-31−$31.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034587. Derived: 12-month figure less the 9-month figure.Report this figure(30.9)Operating income, Q1 FY2024, three months to 2024-03-31−$30.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure(32.8)Operating income, Q2 FY2024, three months to 2024-06-30−$32.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure(33.2)Operating income, Q3 FY2024, three months to 2024-09-30−$33.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure(30.7)Operating income, Q4 FY2024, three months to 2024-12-31−$30.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(29.9)Operating income, Q1 FY2025, three months to 2025-03-31−$29.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure(32.4)Operating income, Q2 FY2025, three months to 2025-06-30−$32.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure(28.0)Operating income, Q3 FY2025, three months to 2025-09-30−$28.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure(31.9)Operating income, Q4 FY2025, three months to 2025-12-31−$31.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(21.6)Operating income, Q1 FY2026, three months to 2026-03-31−$21.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure(22.3)Operating income, Q2 FY2026, three months to 2026-06-30−$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-06, accession 0000950170-25-034587. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$1.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$12.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$24.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$23.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$22.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-06, accession 0000950170-25-034587. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$143.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Net income$m(49.9)Net income, Q3 FY2023, three months to 2023-09-30−$49.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure(29.5)Net income, Q4 FY2023, three months to 2023-12-31−$29.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034587. Derived: 12-month figure less the 9-month figure.Report this figure(28.0)Net income, Q1 FY2024, three months to 2024-03-31−$28.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure(29.9)Net income, Q2 FY2024, three months to 2024-06-30−$29.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure(30.5)Net income, Q3 FY2024, three months to 2024-09-30−$30.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure(28.7)Net income, Q4 FY2024, three months to 2024-12-31−$28.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(28.2)Net income, Q1 FY2025, three months to 2025-03-31−$28.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure(31.2)Net income, Q2 FY2025, three months to 2025-06-30−$31.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure(26.9)Net income, Q3 FY2025, three months to 2025-09-30−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure(30.5)Net income, Q4 FY2025, three months to 2025-12-31−$30.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(20.2)Net income, Q1 FY2026, three months to 2026-03-31−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure(21.4)Net income, Q2 FY2026, three months to 2026-06-30−$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Diluted EPS$ per share(1.16)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure(0.33)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure(0.34)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figurenot reported(4.96)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$4.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure(5.48)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$5.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure(0.29)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figurenot reported(1.88)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure(1.99)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Basic EPS$ per share(1.16)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figurenot reported(0.35)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure(0.33)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure(0.34)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figurenot reported(4.96)Basic EPS, Q1 FY2025, three months to 2025-03-31−$4.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure(5.48)Basic EPS, Q2 FY2025, three months to 2025-06-30−$5.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure(0.29)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figurenot reported(1.88)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure(1.99)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure

Balance sheet

Cash and equivalents$33.1m, Q2 FY2026
Shareholders' equity$120.1m, Q2 FY2026
Adicet Bio, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m183Cash and equivalents, Q3 FY2023, at 2023-09-30$183.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0000950170-23-061128.Report this figure160Cash and equivalents, FY2023, at 2023-12-31$159.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0000950170-25-034587.Report this figure160Cash and equivalents, Q1 FY2024, at 2024-03-31$159.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure224Cash and equivalents, Q2 FY2024, at 2024-06-30$224.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure105Cash and equivalents, Q3 FY2024, at 2024-09-30$105.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure56.5Cash and equivalents, FY2024, at 2024-12-31$56.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001720580-26-000008.Report this figure28.1Cash and equivalents, Q1 FY2025, at 2025-03-31$28.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure34.7Cash and equivalents, Q2 FY2025, at 2025-06-30$34.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure29.1Cash and equivalents, Q3 FY2025, at 2025-09-30$29.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure38.9Cash and equivalents, FY2025, at 2025-12-31$38.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure36.2Cash and equivalents, Q1 FY2026, at 2026-03-31$36.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure33.1Cash and equivalents, Q2 FY2026, at 2026-06-30$33.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Current assets$m186Current assets, Q3 FY2023, at 2023-09-30$185.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061128.Report this figure162Current assets, FY2023, at 2023-12-31$162.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034587.Report this figure250Current assets, Q1 FY2024, at 2024-03-31$250.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059507.Report this figure228Current assets, Q2 FY2024, at 2024-06-30$228.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095745.Report this figure206Current assets, Q3 FY2024, at 2024-09-30$206.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure180Current assets, FY2024, at 2024-12-31$180.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001720580-26-000008.Report this figure154Current assets, Q1 FY2025, at 2025-03-31$153.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure128Current assets, Q2 FY2025, at 2025-06-30$127.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure106Current assets, Q3 FY2025, at 2025-09-30$106.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure161Current assets, FY2025, at 2025-12-31$160.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure140Current assets, Q1 FY2026, at 2026-03-31$140.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure121Current assets, Q2 FY2026, at 2026-06-30$120.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Total assets$m233Total assets, Q3 FY2023, at 2023-09-30$233.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061128.Report this figure207Total assets, FY2023, at 2023-12-31$207.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034587.Report this figure293Total assets, Q1 FY2024, at 2024-03-31$293.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059507.Report this figure269Total assets, Q2 FY2024, at 2024-06-30$268.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-095745.Report this figure246Total assets, Q3 FY2024, at 2024-09-30$246.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure220Total assets, FY2024, at 2024-12-31$220.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001720580-26-000008.Report this figure191Total assets, Q1 FY2025, at 2025-03-31$191.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure163Total assets, Q2 FY2025, at 2025-06-30$163.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure140Total assets, Q3 FY2025, at 2025-09-30$140.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure192Total assets, FY2025, at 2025-12-31$192.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure169Total assets, Q1 FY2026, at 2026-03-31$169.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure148Total assets, Q2 FY2026, at 2026-06-30$148.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Current liabilities$m19.8Current liabilities, Q3 FY2023, at 2023-09-30$19.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061128.Report this figure19.3Current liabilities, FY2023, at 2023-12-31$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034587.Report this figure17.5Current liabilities, Q1 FY2024, at 2024-03-31$17.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059507.Report this figure17.9Current liabilities, Q2 FY2024, at 2024-06-30$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095745.Report this figure19.4Current liabilities, Q3 FY2024, at 2024-09-30$19.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure19.4Current liabilities, FY2024, at 2024-12-31$19.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001720580-26-000008.Report this figure16.4Current liabilities, Q1 FY2025, at 2025-03-31$16.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure17.1Current liabilities, Q2 FY2025, at 2025-06-30$17.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure18.9Current liabilities, Q3 FY2025, at 2025-09-30$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure21.5Current liabilities, FY2025, at 2025-12-31$21.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure18.3Current liabilities, Q1 FY2026, at 2026-03-31$18.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure18.0Current liabilities, Q2 FY2026, at 2026-06-30$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Total liabilities$m38.6Total liabilities, Q3 FY2023, at 2023-09-30$38.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061128.Report this figure37.1Total liabilities, FY2023, at 2023-12-31$37.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034587.Report this figure34.3Total liabilities, Q1 FY2024, at 2024-03-31$34.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059507.Report this figure33.7Total liabilities, Q2 FY2024, at 2024-06-30$33.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-095745.Report this figure34.4Total liabilities, Q3 FY2024, at 2024-09-30$34.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure33.6Total liabilities, FY2024, at 2024-12-31$33.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001720580-26-000008.Report this figure29.8Total liabilities, Q1 FY2025, at 2025-03-31$29.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure29.6Total liabilities, Q2 FY2025, at 2025-06-30$29.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure31.3Total liabilities, Q3 FY2025, at 2025-09-30$31.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure33.1Total liabilities, FY2025, at 2025-12-31$33.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure29.3Total liabilities, Q1 FY2026, at 2026-03-31$29.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure28.0Total liabilities, Q2 FY2026, at 2026-06-30$28.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure
Shareholders' equity$m195Shareholders' equity, Q3 FY2023, at 2023-09-30$194.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure170Shareholders' equity, FY2023, at 2023-12-31$170.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001720580-26-000008.Report this figure259Shareholders' equity, Q1 FY2024, at 2024-03-31$258.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure235Shareholders' equity, Q2 FY2024, at 2024-06-30$235.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure212Shareholders' equity, Q3 FY2024, at 2024-09-30$211.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure187Shareholders' equity, FY2024, at 2024-12-31$186.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure161Shareholders' equity, Q1 FY2025, at 2025-03-31$161.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure133Shareholders' equity, Q2 FY2025, at 2025-06-30$133.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure109Shareholders' equity, Q3 FY2025, at 2025-09-30$109.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure159Shareholders' equity, FY2025, at 2025-12-31$159.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure140Shareholders' equity, Q1 FY2026, at 2026-03-31$140.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure120Shareholders' equity, Q2 FY2026, at 2026-06-30$120.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure

Cash flow

Operating cash flow−$19.8m, Q2 FY2026
Capital expenditure$202.0k, Q2 FY2026
Adicet Bio, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(21.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122253. Derived: 9-month figure less the 6-month figure.Report this figure(23.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$23.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0000950170-25-034587. Derived: 12-month figure less the 9-month figure.Report this figure(22.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$22.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure(23.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104978. Derived: 6-month figure less the 3-month figure.Report this figure(22.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$22.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266880. Derived: 9-month figure less the 6-month figure.Report this figure(24.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$24.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(25.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$25.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure(26.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$26.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001720580-26-000050. Derived: 6-month figure less the 3-month figure.Report this figure(22.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$22.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266880. Derived: 9-month figure less the 6-month figure.Report this figure(20.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$20.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(21.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$21.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure(19.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$19.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001720580-26-000050. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$906.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122253. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$136.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0000950170-25-034587. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$239.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$302.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104978. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$401.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266880. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$176.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001720580-26-000050. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$209.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266880. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001720580-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$202.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001720580-26-000050. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)10.75m, Q2 FY2026
Adicet Bio, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares41.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3041,642,815 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061128.Report this figure43.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3142,955,688 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059507.Report this figure43.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3042,957,035 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-095745.Report this figure43.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3042,980,641 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122253.Report this figure79.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3179,071,652 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064448.Report this figure90.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3090,632,045 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104978.Report this figure90.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3090,846,293 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure5.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-315,691,965 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure5.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-305,692,816 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure91.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3091,086,464 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266880.Report this figure10.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3110,744,621 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001720580-26-000037.Report this figure10.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3010,745,553 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure

Shares outstanding: 9.36mShares outstanding, period not labelled, at 2026-08-039,361,490 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001720580-26-000050.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.